1Laurenzi GA, Potter RT, Kass EH. Bacteriologic flora of the lower respiratory tract. N Engl J Med, 1961, 265:1273-1278.
2Murphy TF, Sethi S. Bacterial infection in chronic obstructive pulmonary disease. Am Rev Respir Dis, 1992, 146:1067-1083.
3Monso E, Ruiz J, Rosell A, et al. Bacterial infection in chronic obstructive pulmonary disease. A study of stable and exacerbated outpatients using the protected specimen brush. Am J Respir Crit Care Med, 1995, 152(4 Pt 1): 1316-1320.
4Bandi V, Apicella MA, Mason E, et al. Nontypeable Haemophilus influenzae in the lower respiratory tract of patients with chronic bronchitis. Am J Respir Crit Care Med, 2001, 164:2114-2119.
5Murphy TF, Brauer AL, Schiffmacher AT, et al. Persistent colonization by Haemophilus influenzae in chronic obstructive pulmonary disease. Am J Respir Crit Care Med, 2004, 170:266-272.
6Sethi S, Evans N, Grant BJB, et al. Acquisition of a new bacterial strain and occurrence of exacerbations of chronic obstructive pulmonary disease. N Engl J Med, 2002, 347:465-471.
7Sethi S, Wrona C, Grant BJ, et al. Strain-specific immune response to Haemophilus influenzae in chronic obstructive pulmonary disease. Am J Respir Crit Care Med, 2004, 169: 448-453.
8Sethi S. New developments in the pathogenesis of acute exacerbations of chronic obstructive pulmonary disease. Curr Opin Infect Dis, 2004, 17: 113-119.
9Berenson CS, Murphy TF, Wrona CT, et al. Outer membrane protein P6 of nontypeable Haemophilus influenzae is a potent and selective inducer of human macrophage proinflammatory cytokines. Infect Immun, 2005, 73: 2728-2735.
10Fuke S, Betsuyaku T, Nasuhara Y, et al. Chemokines in bronchiolar epithelium in the development of chronic obstructive pulmonary disease. Am J Respir Cell Mol Biol, 2004, 31: 405-412.
7Sethi S; Murphy TF. Bacterial infection in chronic obstructive pulmonary disease in 2000: a state-of-the-art review[J]. Clin Microbiology Rev, 2001, 14 (2): 336-363.
8Maltais F, Ostinelli J, Bourbeau J, et al. Comparison of nebulized budesonide and oral prednisolone with placebo in the treatment of acute exacerbations of chronic obstructive pulmonary disease: a randomized controlled trial [J]. Am J Respir Crit Care Med, 2002, 165 (5); 698-703.
9NSEIR S, Di POMPEO C, CAVESTRI B, et al. Multiple--durg-resistant bacteria in patients with severe acute exacerbation of chronic obstructive pulmonary disease : Prevalence, risk factors, and outcome [ J ]. Crit Care Med,2006,34(12) :2959-2966.
10RAM F S, RODRIGNEZ-ROISIN R, GRANADOS-NAVARRETE A, et al. Antibiotics for exacerbations of chronic obstruetructive pulmonary disease[J]. Cochrane Database Syst Rev,2006,19(2) :CD004403.
